[HTML][HTML] Ex vivo engineered human plasma cells exhibit robust protein secretion and long-term engraftment in vivo
Due to their unique longevity and capacity to secrete high levels of protein, plasma B cells
have the potential to be used as a cell therapy for protein replacement. Here, we show that …
have the potential to be used as a cell therapy for protein replacement. Here, we show that …
Ex vivo engineered human plasma cells exhibit robust protein secretion and long-term engraftment in vivo
RYH Cheng, KL Hung, T Zhang… - Nature …, 2022 - econpapers.repec.org
Due to their unique longevity and capacity to secrete high levels of protein, plasma B cells
have the potential to be used as a cell therapy for protein replacement. Here, we show that …
have the potential to be used as a cell therapy for protein replacement. Here, we show that …
Ex vivo engineered human plasma cells exhibit robust protein secretion and long-term engraftment in vivo.
RYH Cheng, KL Hung, T Zhang… - Nature …, 2022 - search.ebscohost.com
Due to their unique longevity and capacity to secrete high levels of protein, plasma B cells
have the potential to be used as a cell therapy for protein replacement. Here, we show that …
have the potential to be used as a cell therapy for protein replacement. Here, we show that …
Ex vivo engineered human plasma cells exhibit robust protein secretion and long-term engraftment in vivo.
RY Cheng, KL Hung, T Zhang, CM Stoffers… - Nature …, 2022 - europepmc.org
Due to their unique longevity and capacity to secrete high levels of protein, plasma B cells
have the potential to be used as a cell therapy for protein replacement. Here, we show that …
have the potential to be used as a cell therapy for protein replacement. Here, we show that …
Ex vivo engineered human plasma cells exhibit robust protein secretion and long-term engraftment in vivo
RYH Cheng, KL Hung, T Zhang… - Nature …, 2022 - pubmed.ncbi.nlm.nih.gov
Due to their unique longevity and capacity to secrete high levels of protein, plasma B cells
have the potential to be used as a cell therapy for protein replacement. Here, we show that …
have the potential to be used as a cell therapy for protein replacement. Here, we show that …
Ex vivo engineered human plasma cells exhibit robust protein secretion and long-term engraftment in vivo
RYH Cheng, KL Hung, T Zhang… - Nature …, 2022 - ui.adsabs.harvard.edu
Due to their unique longevity and capacity to secrete high levels of protein, plasma B cells
have the potential to be used as a cell therapy for protein replacement. Here, we show that …
have the potential to be used as a cell therapy for protein replacement. Here, we show that …
Ex vivo engineered human plasma cells exhibit robust protein secretion and long-term engraftment in vivo
RYH Cheng, KL Hung, T Zhang, CM Stoffers… - Nature …, 2022 - ideas.repec.org
Due to their unique longevity and capacity to secrete high levels of protein, plasma B cells
have the potential to be used as a cell therapy for protein replacement. Here, we show that …
have the potential to be used as a cell therapy for protein replacement. Here, we show that …
[HTML][HTML] Ex vivo engineered human plasma cells exhibit robust protein secretion and long-term engraftment in vivo
RYH Cheng, KL Hung, T Zhang, CM Stoffers… - Nature …, 2022 - ncbi.nlm.nih.gov
Due to their unique longevity and capacity to secrete high levels of protein, plasma B cells
have the potential to be used as a cell therapy for protein replacement. Here, we show that …
have the potential to be used as a cell therapy for protein replacement. Here, we show that …
Ex vivo engineered human plasma cells exhibit robust protein secretion and long-term engraftment in vivo.
RY Cheng, KL Hung, T Zhang, CM Stoffers… - Nature …, 2022 - europepmc.org
Due to their unique longevity and capacity to secrete high levels of protein, plasma B cells
have the potential to be used as a cell therapy for protein replacement. Here, we show that …
have the potential to be used as a cell therapy for protein replacement. Here, we show that …